Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of Respiratory Syncytial Virus disease among infants in Canada: a simulation study
Article in The Lancet Regional Health - Americas (November 2023)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Article in The Lancet Regional Health - Americas (November 2023)
Preprint in medRxiv (July 2023)
Article in British Journal of Clinical Pharmacology (October 2021)